SCHEMBL14831925

SCHEMBL14831925

O=CCc1cc2ccccn2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 7/20 0.44
DRD3 P35462 7/20 0.44
DRD4 P21917 3/20 0.44
DRD1 P21728 1/20 0.44
MAP4K4 O95819 1/20 0.43
ABL1 P00519 1/20 0.43
MAPK8 P45983 1/20 0.43
CSNK1A1 P48729 1/20 0.43
CDK7 P50613 1/20 0.43
TYRO3 Q06418 1/20 0.43
LRRK2 Q5S007 1/20 0.43
AURKB Q96GD4 1/20 0.43
CLK4 Q9HAZ1 1/20 0.43
PIM2 Q9P1W9 1/20 0.43
DYRK1B Q9Y463 1/20 0.43
PDE10A Q9Y233 1/20 0.41
KDM4E B2RXH2 2/20 0.41
HSD17B10 Q99714 1/20 0.41
TP53 P04637 3/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL259378 0.78 DRD2 (0.48) DRD2DRD3DRD4DRD1MAP4K4
SCHEMBL30971750 0.77 DRD2 (0.50) DRD2DRD3DRD4DRD1MAP4K4
SCHEMBL261030 0.77 DRD2 (0.47) DRD2DRD3DRD4DRD1MAP4K4
SCHEMBL13540953 0.77 DRD2 (0.47) DRD2DRD3DRD4DRD1MAP4K4
SCHEMBL2024811 0.75 MAP4K4 (0.53) DRD2DRD3DRD4DRD1MAP4K4
SCHEMBL967558 0.74 DRD2 (0.45) DRD2DRD3DRD4DRD1MAP4K4
SCHEMBL969735 0.74 DRD2 (0.45) DRD2DRD3DRD4DRD1MAP4K4
SCHEMBL11655446 0.74 MAP4K4 (0.47) DRD2DRD3DRD4DRD1MAP4K4
SCHEMBL4127301 0.73 HDAC2 (0.48) MAP4K4ABL1MAPK8CSNK1A1CDK7
SCHEMBL24656101 0.72 NR3C1 (0.47) DRD2DRD3DRD4DRD1MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022210479-A1 USE OF AZEPANE DERIVATIVE FOR TREATMENT, AMELIORATION OR PREVENTION OF κ-OPIOID RECEPTOR-RELATED DISEASES 日本ケミファ株式会社 2022-10-06 WO disclosed
EP-2760831-A1 VIRAL REPLICATION INHIBITORS Katholieke Universiteit Leuven (BE) 2014-08-06 EP disclosed
WO-2013045516-A1 VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2013-04-04 WO disclosed